CGM and Group Intervention for Prediabetes Study
Summary
NIH registered ClinicalTrials.gov study NCT07543068, a randomized investigation examining whether combining continuous glucose monitor (CGM) devices with group behavioral intervention sessions can reduce A1C levels and improve self-management confidence in adults with prediabetes. The study will enroll participants with confirmed prediabetes or non-diabetic hyperglycemia and deliver interventions through regular small-group educational meetings alongside real-time glucose monitoring. Results will inform diabetes prevention strategies.
About this source
GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 578 changes logged to date.
What changed
NIH registered a new clinical trial on ClinicalTrials.gov under identifier NCT07543068. The study will investigate whether combining continuous glucose monitor (CGM) devices with group behavioral intervention visits can help adults with prediabetes lower their A1C levels and improve health self-management confidence. Participants will attend regular small-group educational sessions covering nutrition, physical activity, and stress management while simultaneously using CGM devices to receive real-time feedback on how lifestyle choices affect blood glucose levels.
Healthcare providers and patients seeking information about ongoing diabetes prevention research can reference this registry entry for study design, eligibility criteria, and anticipated outcomes. The study represents an informational addition to the public clinical trials database and creates no compliance obligations for healthcare organizations.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Diabetes Prevention by Group Intervention and CGM Use in Pre-diabetic Adults
N/A NCT07543068 Kind: NA Apr 21, 2026
Abstract
This study is being done to find better ways to help people with prediabetes prevent or delay the development of type 2 diabetes. Prediabetes means your blood sugar is higher than normal, but not high enough to be diagnosed with diabetes. It is often silent, but without changes in diet and activity, many people progress to a diagnosis of diabetes within a few years.
The study combines two strategies:
- Group visits - small, regular meetings where patients learn about healthy eating, physical activity, and stress management.
- Continuous Glucose Monitors (CGMs) - small wearable sensors that measure blood sugar all day and show how food, movement, and sleep affect it in real time.
By bringing these two tools together, the research hopes to help participants better understand their own bodies and make lasting lifestyle changes.
What is the purpose of this research?
The purpose of this research is to find out whether using a CGM device together with group sessions can help people with prediabetes lower their average blood sugar (measured by A1C) and improve confidence in managing their health.
Conditions: Pre Diabetic, Hyperglycaemia (Non Diabetic)
Interventions: Combines group sessions and CGM-based behavioral feedback
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.